Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
EFNB3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MYO1C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZKSCAN3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
XIST - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
PAPOLA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DDX6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAB23 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MFSD14B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LOC100996756 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CKAP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEMA4G - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HACD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC643201 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPP1R3F - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HSPH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FGF12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SALL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CISH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on